Compare $BCAB vs $BRTX | Chartloom

Compare

$BCAB vs $BRTX

Bioatla Inc · BioRestorative Therapies Inc

BCAB

Bioatla Inc

BRTX

BioRestorative Therapies Inc

Compare $BCAB vs $BRTX

Comparing Bioatla Inc and BioRestorative Therapies Inc

BCABBioatla Inc

BRTXBioRestorative Therapies Inc

BCABBioatla Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-22.7%

YTD performance

-94.4%

52W performance

-96.7%

FCF yield

-943.1%

BRTXBioRestorative Therapies Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-8.5%

YTD performance

-92.2%

52W performance

-94.2%

FCF yield

-24.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCAB

BRTX

Detailed metrics comparison

BCAB

Bioatla Inc

BRTX

BioRestorative Therapies Inc

Market Cap

BCAB$2M

BRTX$49M

Enterprise Value

BCAB$946K

BRTX$46M

Price

BCAB$1.50

BRTX$1.91

P/E Ratio

BCABN/A

BRTXN/A

P/S Ratio

BCAB0.29x

BRTX135.98x

EV/Sales

BCAB0.11x

BRTX127.28x

EV/EBITDA

BCAB0.00x

BRTX0.00x

P/B Ratio

BCAB4.57x

BRTX0.98x

P/FCF Ratio

BCABN/A

BRTXN/A

EV/FCF

BCAB-0.04x

BRTX-3.83x

PEG Ratio

BCABN/A

BRTXN/A

Forward P/E (NTM)

BCABN/A

BRTXN/A

Forward P/S (NTM)

BCABN/A

BRTXN/A

Revenue (TTM)

BCAB$9M

BRTX$358K

Revenue Growth (YoY)

BCAB-22.7%

BRTX-8.5%

Forward Rev Growth

BCAB0.0%

BRTX64.6%

Gross Margin (TTM)

BCAB0.0%

BRTX92.1%

Operating Margin (TTM)

BCAB0.0%

BRTX0.0%

EBITDA Margin (TTM)

BCAB-369.8%

BRTX-3915.8%

Net Margin (TTM)

BCAB-370.0%

BRTX-3089.3%

FCF Margin (TTM)

BCAB-276.3%

BRTX-3324.3%

Net Income (TTM)

BCAB$-31M

BRTX$-11M

FCF (TTM)

BCAB$-23M

BRTX$-12M

EPS (TTM)

BCAB-$18.93

BRTX-$12.47

ROE (TTM)

BCAB-35792.0%

BRTX-42384.0%

ROA (TTM)

BCAB-26317.0%

BRTX-19330.0%

ROIC (TTM)

BCAB-35792.0%

BRTX-42384.0%

Cash

BCAB$2M

BRTX$3M

Debt

BCAB$0

BRTX$0

Net Cash/Debt

BCAB$2M

BRTX$3M

Current Ratio (TTM)

BCAB0.20x

BRTX2.35x

Quick Ratio (TTM)

BCAB0.17x

BRTX2.23x

Debt/Equity (TTM)

BCAB0.00x

BRTX0.00x

Debt/Assets (TTM)

BCAB0.0%

BRTX0.0%

Interest Coverage (TTM)

BCABN/A

BRTXN/A

Net Debt/EBITDA (TTM)

BCAB0.00x

BRTX0.00x

Beta

BCAB0.63

BRTX0.80

52W Performance

BCAB-96.7%

BRTX-94.2%

YTD Performance

BCAB-94.4%

BRTX-92.2%

% from 52W High

BCAB-97.9%

BRTX-94.5%

% from 52W Low

BCAB40.2%

BRTX9.1%

Asset Turnover (TTM)

BCAB0.73x

BRTX0.06x

FCF Yield (TTM)

BCAB-943.1%

BRTX-24.4%

Earnings Yield (TTM)

BCAB-1263.2%

BRTX-22.7%

Dividend Yield (TTM)

BCABN/A

BRTXN/A

Rule of 40

BCAB-299.0

BRTX-3,332.8

EV/GP/RG

BCABN/A

BRTX2.12

Ticker research

View BCAB research View BRTX research

Metric	BCAB Bioatla Inc	BRTX BioRestorative Therapies Inc
Market & Valuation
Market Cap	$2M	$49M
Enterprise Value	$946K	$46M
Price	$1.50	$1.91
P/E Ratio	N/A	N/A
P/S Ratio	0.29x	135.98x
EV/Sales	0.11x	127.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.57x	0.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.04x	-3.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$9M	$358K
Revenue Growth (YoY)	-22.7%	-8.5%
Forward Rev Growth	0.0%	64.6%
Profitability
Gross Margin (TTM)	0.0%	92.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-369.8%	-3915.8%
Net Margin (TTM)	-370.0%	-3089.3%
FCF Margin (TTM)	-276.3%	-3324.3%
Net Income (TTM)	$-31M	$-11M
FCF (TTM)	$-23M	$-12M
EPS (TTM)	-$18.93	-$12.47
ROE (TTM)	-35792.0%	-42384.0%
ROA (TTM)	-26317.0%	-19330.0%
ROIC (TTM)	-35792.0%	-42384.0%
Financial Health
Cash	$2M	$3M
Debt	$0	$0
Net Cash/Debt	$2M	$3M
Current Ratio (TTM)	0.20x	2.35x
Quick Ratio (TTM)	0.17x	2.23x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	0.80
52W Performance	-96.7%	-94.2%
YTD Performance	-94.4%	-92.2%
% from 52W High	-97.9%	-94.5%
% from 52W Low	40.2%	9.1%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.06x
FCF Yield (TTM)	-943.1%	-24.4%
Earnings Yield (TTM)	-1263.2%	-22.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-299.0	-3,332.8
EV/GP/RG	N/A	2.12
Ticker research	View BCAB research	View BRTX research

Valuation

P/S Ratio

BCAB

0.29x

BRTX

135.98x

EV/FCF

BRTX

-3.83x

BCAB

-0.04x

Growth & revenue

Revenue Growth TTM

BRTX

-8.5%

BCAB

-22.7%

Forward Revenue Growth

BRTX

64.6%

BCAB

0.0%

Profitability & performance

Gross Margin

BRTX

92.1%

BCAB

0.0%

ROE

BCAB

-35792.0%

BRTX

-42384.0%

FCF Yield %

BRTX

-24.4%

BCAB

-943.1%

52-Week Performance

BRTX

-94.2%

BCAB

-96.7%

Detailed metrics comparison

BCAB

Bioatla Inc

BRTX

BioRestorative Therapies Inc

Market Cap

BCAB$2M

BRTX$49M

Enterprise Value

BCAB$946K

BRTX$46M

Price

BCAB$1.50

BRTX$1.91

P/E Ratio

BCABN/A

BRTXN/A

P/S Ratio

BCAB0.29x

BRTX135.98x

EV/Sales

BCAB0.11x

BRTX127.28x

EV/EBITDA

BCAB0.00x

BRTX0.00x

P/B Ratio

BCAB4.57x

BRTX0.98x

P/FCF Ratio

BCABN/A

BRTXN/A

EV/FCF

BCAB-0.04x

BRTX-3.83x

PEG Ratio

BCABN/A

BRTXN/A

Forward P/E (NTM)

BCABN/A

BRTXN/A

Forward P/S (NTM)

BCABN/A

BRTXN/A

Revenue (TTM)

BCAB$9M

BRTX$358K

Revenue Growth (YoY)

BCAB-22.7%

BRTX-8.5%

Forward Rev Growth

BCAB0.0%

BRTX64.6%

Gross Margin (TTM)

BCAB0.0%

BRTX92.1%

Operating Margin (TTM)

BCAB0.0%

BRTX0.0%

EBITDA Margin (TTM)

BCAB-369.8%

BRTX-3915.8%

Net Margin (TTM)

BCAB-370.0%

BRTX-3089.3%

FCF Margin (TTM)

BCAB-276.3%

BRTX-3324.3%

Net Income (TTM)

BCAB$-31M

BRTX$-11M

FCF (TTM)

BCAB$-23M

BRTX$-12M

EPS (TTM)

BCAB-$18.93

BRTX-$12.47

ROE (TTM)

BCAB-35792.0%

BRTX-42384.0%

ROA (TTM)

BCAB-26317.0%

BRTX-19330.0%

ROIC (TTM)

BCAB-35792.0%

BRTX-42384.0%

Cash

BCAB$2M

BRTX$3M

Debt

BCAB$0

BRTX$0

Net Cash/Debt

BCAB$2M

BRTX$3M

Current Ratio (TTM)

BCAB0.20x

BRTX2.35x

Quick Ratio (TTM)

BCAB0.17x

BRTX2.23x

Debt/Equity (TTM)

BCAB0.00x

BRTX0.00x

Debt/Assets (TTM)

BCAB0.0%

BRTX0.0%

Interest Coverage (TTM)

BCABN/A

BRTXN/A

Net Debt/EBITDA (TTM)

BCAB0.00x

BRTX0.00x

Beta

BCAB0.63

BRTX0.80

52W Performance

BCAB-96.7%

BRTX-94.2%

YTD Performance

BCAB-94.4%

BRTX-92.2%

% from 52W High

BCAB-97.9%

BRTX-94.5%

% from 52W Low

BCAB40.2%

BRTX9.1%

Asset Turnover (TTM)

BCAB0.73x

BRTX0.06x

FCF Yield (TTM)

BCAB-943.1%

BRTX-24.4%

Earnings Yield (TTM)

BCAB-1263.2%

BRTX-22.7%

Dividend Yield (TTM)

BCABN/A

BRTXN/A

Rule of 40

BCAB-299.0

BRTX-3,332.8

EV/GP/RG

BCABN/A

BRTX2.12

Ticker research

View BCAB research View BRTX research

Metric	BCAB Bioatla Inc	BRTX BioRestorative Therapies Inc
Market & Valuation
Market Cap	$2M	$49M
Enterprise Value	$946K	$46M
Price	$1.50	$1.91
P/E Ratio	N/A	N/A
P/S Ratio	0.29x	135.98x
EV/Sales	0.11x	127.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.57x	0.98x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.04x	-3.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$9M	$358K
Revenue Growth (YoY)	-22.7%	-8.5%
Forward Rev Growth	0.0%	64.6%
Profitability
Gross Margin (TTM)	0.0%	92.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-369.8%	-3915.8%
Net Margin (TTM)	-370.0%	-3089.3%
FCF Margin (TTM)	-276.3%	-3324.3%
Net Income (TTM)	$-31M	$-11M
FCF (TTM)	$-23M	$-12M
EPS (TTM)	-$18.93	-$12.47
ROE (TTM)	-35792.0%	-42384.0%
ROA (TTM)	-26317.0%	-19330.0%
ROIC (TTM)	-35792.0%	-42384.0%
Financial Health
Cash	$2M	$3M
Debt	$0	$0
Net Cash/Debt	$2M	$3M
Current Ratio (TTM)	0.20x	2.35x
Quick Ratio (TTM)	0.17x	2.23x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	0.80
52W Performance	-96.7%	-94.2%
YTD Performance	-94.4%	-92.2%
% from 52W High	-97.9%	-94.5%
% from 52W Low	40.2%	9.1%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.06x
FCF Yield (TTM)	-943.1%	-24.4%
Earnings Yield (TTM)	-1263.2%	-22.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-299.0	-3,332.8
EV/GP/RG	N/A	2.12
Ticker research	View BCAB research	View BRTX research